Every 8-K that Healthcare Tr Amer Inc (HR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow HR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HR filings page.
Healthcare Realty Trust Incorporated and Healthcare Realty Holdings, L.P. filed an automatic shelf registration statement on Form S-3ASR with the SEC on July 31, 2026, together with a prospectus supplement for an existing at-the-market equity program for up to $1,000,000,000 of Class A common stock.
The new registration statement replaced a prior automatic shelf filed on August 8, 2023, which was deemed terminated when the new statement became effective on July 31, 2026. Because no shares had been sold previously under the at-the-market program, the full $1,000,000,000 of common stock capacity remains available for sale under the equity distribution agreements, the new registration statement, and the ATM prospectus supplement. An opinion of Venable LLP regarding the validity of the common stock issuable under this program was filed as an exhibit.
Healthcare Realty Trust reported second quarter 2026 GAAP net loss of $(0.13) per share, NAREIT FFO of $0.36 per share and Normalized FFO of $0.41 per share. Funds available for distribution were $109.4 million with a 76% payout ratio.
Same store cash NOI grew 5.1%, supported by 1.5 million square feet of lease executions, 88.5% tenant retention and 4.8% cash leasing spreads. Since last quarter the company arranged about $200 million of joint venture acquisitions and $83 million of dispositions and ended June 30 with roughly $1.6 billion of liquidity and Run Rate Net Debt to Adjusted EBITDA of 5.6x.
The company issued $700 million of 3.00% Exchangeable Senior Notes due 2032, largely to refinance $600 million notes due 2026, repurchased 3.8 million shares for $75 million and secured a $400 million delayed draw term loan. The board declared a $0.24 per share dividend and increased 2026 Normalized FFO guidance to $1.62–$1.66 per share and Same Store Cash NOI growth guidance to 4.25%–5.00%.
Healthcare Realty Trust Incorporated reported the results of its annual meeting of stockholders held on May 19, 2026. Stockholders representing 326,851,561 shares, or about 94.32% of outstanding common stock, were present in person or by proxy, indicating very high participation.
All nominated directors were elected for one-year terms, each receiving more than 90% support of votes cast, with several above 98%. Stockholders also ratified Deloitte & Touche LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, with 99.86% of votes cast in favor. In addition, stockholders approved, on a non-binding advisory basis, the company’s executive compensation (“say-on-pay”) with 91.68% support.
Healthcare Realty Trust Incorporated entered into a new senior unsecured term loan agreement providing a $400.0 million delayed draw term loan facility for its operating partnership. The facility can be drawn on the closing date and in up to three additional draws until the first anniversary of the closing date and matures on May 15, 2029.
The agreement includes an accordion feature allowing up to an additional $100.0 million of term loans, subject to lender commitments. Pricing is based on the borrower’s unsecured long-term debt ratings, with an initial margin of 0.90% per annum over Term SOFR or Daily Simple SOFR and 0.00% over the base rate. A 0.20% per annum commitment fee applies on unfunded commitments starting on the ninety-first day after closing. As of the closing date, no borrowings were outstanding. The facility has no required amortization, permits voluntary prepayment without penalty, and includes customary covenants and events of default for a facility of this type.
Healthcare Realty Trust Incorporated completed a private offering of $700 million in 3.00% Exchangeable Senior Notes due 2032 through its subsidiary Healthcare Realty Holdings, L.P., fully and unconditionally guaranteed on a senior, unsecured basis by the company. The notes pay semi-annual interest and are exchangeable into common stock at an initial rate of 43.4660 shares per $1,000 principal amount, implying an initial exchange price of about $23.01 per share, with customary adjustment and make-whole features. The issuer can settle exchanges in cash or in a mix of cash and shares and may redeem the notes from 2030 if stock price and liquidity conditions are met. A related registration rights agreement requires a resale registration statement for shares issuable upon exchange and provides for additional interest or a 3% maturity premium if certain registration defaults occur. The company also entered into capped call transactions covering the shares underlying the notes, with an initial cap price of $27.41 per share and a cost of about $28 million, which are expected to reduce potential dilution or offset cash payments above principal upon exchange, subject to the cap.
Healthcare Realty Trust Incorporated is raising new debt through its operating partnership, which has priced a private offering of $600 million aggregate principal amount of 3.00% exchangeable senior notes due 2032, upsized from a previously announced $500 million. The notes are senior, unsecured obligations of Healthcare Realty Holdings, L.P. and are fully and unconditionally guaranteed by Healthcare Realty.
Noteholders can exchange the notes for cash and, if applicable, shares of class A common stock at an initial exchange rate of 43.4660 shares per $1,000 of notes, implying an exchange price of about $23.01 per share, a 17.5% premium to the $19.58 share price on May 4, 2026. A capped call with an initial cap price of about $27.41 per share (a 40.0% premium) is intended to reduce potential dilution.
Healthcare Realty L.P. expects net proceeds of about $582.6 million (or $680.1 million if the underwriters’ option is fully exercised). It plans to spend $24.0 million on capped call transactions, about $75.0 million to repurchase approximately 3.83 million shares of class A common stock, and use the remainder, together with borrowings under its unsecured revolving credit facility, to repay its 3.500% Senior Notes due 2026.
Healthcare Realty Trust reported mixed first quarter 2026 results with stronger cash flow metrics and higher full-year guidance. GAAP net loss was essentially breakeven at $(0.00) per share, while NAREIT FFO held at $0.35 per share and Normalized FFO rose to $0.41 per share from $0.39 a year earlier. Revenue was $279.0 million versus $299.0 million in the prior-year quarter.
The portfolio produced Same Store Cash NOI growth of 6.9% with 93.5% tenant retention, 4.2% cash leasing spreads and 2.0 million square feet of lease executions. Funds available for distribution were $112.9 million with a 75% payout ratio, supporting a $0.24 per share dividend. The company raised 2026 Normalized FFO guidance to $1.59–$1.65 per share and Same Store Cash NOI growth guidance to 3.75%–4.75%. It also repurchased $100 million of stock, completed about $125 million of acquisitions and dispositions, and ended the quarter with Net Debt to Adjusted EBITDA of 5.5x and roughly $1.2 billion of liquidity.
Healthcare Realty Trust furnished a business update presentation outlining 2025 results, balance sheet progress, and its Healthcare Realty 2.0 strategic plan. The outpatient medical REIT owns 33 million square feet across 562 properties and reported 2025 normalized FFO of $1.61 per share, with same-store cash NOI up 4.8% and occupancy at 92.1%.
Net debt to adjusted EBITDA improved to 5.4x after about $1.2 billion of asset sales, $650 million of term loan repayments, and $250 million of senior note repayments, contributing to $1.4 billion of liquidity and BBB/Baa2 credit ratings. The company right-sized its dividend to $0.24 per quarter (5.2% yield on a $0.96 annualized rate) and repurchased $50 million of stock in January 2026, with $450 million of authorization remaining.
For 2026, guidance calls for normalized FFO of $1.58–$1.64 per share and same-store cash NOI growth of 3.5%–4.5%. Management highlights high occupancy, a largely fixed-rate debt stack with a 3.2% weighted average rate, a 36% total debt-to-assets ratio, and targeted 9%–12% returns on a ~$300 million redevelopment pipeline as key drivers of future earnings growth.
Healthcare Realty Trust Incorporated reported that its Audit Committee has appointed Deloitte & Touche LLP as the company’s independent registered public accounting firm, effective February 19, 2026, replacing BDO USA, P.C.
BDO’s audit reports on the company’s financial statements for the years ended December 31, 2024 and 2025 contained no adverse opinions, disclaimers, or qualifications. The company states there were no disagreements or reportable events with BDO under the SEC’s Regulation S-K definitions during those years and through February 19, 2026. BDO provided a letter agreeing with the company’s description of these matters, filed as Exhibit 16.
Healthcare Realty Trust reported solid operating momentum for Q4 2025 while continuing to reshape its portfolio and balance sheet. For the quarter, GAAP net income was $14.4 million, or $0.04 per share, with NAREIT FFO of $0.36 and Normalized FFO of $0.40 per share. Same-store cash NOI grew 5.5%, helped by 82.7% tenant retention and 3.7% cash leasing spreads, and the company executed 1.5 million square feet of leases.
For full-year 2025, the company posted a GAAP net loss of $0.71 per share but generated NAREIT FFO of $1.38 and Normalized FFO of $1.61 per share, supported by 4.8% same-store cash NOI growth. Management completed $1.2 billion of asset sales at a 6.7% blended cap rate, reduced Net Debt to Adjusted EBITDA to 5.4x from 6.1x, repaid roughly $650 million of term loans and $250 million of senior notes, and extended its $1.5 billion revolver to July 2030. The Board declared a $0.24 per share dividend and the company repurchased 2.9 million shares for $50 million. New 2026 guidance calls for earnings per share between $(0.05) and $0.05, NAREIT FFO per share of $1.44–$1.50, Normalized FFO per share of $1.58–$1.64, and same-store cash NOI growth of 3.5–4.5%. Healthcare Realty also established an inaugural commercial paper program of up to $600 million to expand its short-term funding options.
Healthcare Realty Trust Incorporated is changing its senior finance leadership. The Board appointed Daniel Gabbay as Executive Vice President and Chief Financial Officer effective January 12, 2026. He joins from RBC Capital Markets’ real estate investment banking group with a long background covering healthcare real estate investment trusts.
Under his employment agreement, Mr. Gabbay will receive a base salary of $500,000, a target annual cash incentive of $625,000 (not less than target for 2026), and 2026 equity incentives with a target value of $1,375,000, plus a one-time make-whole restricted stock award valued at $2,750,000 that vests over four years and relocation benefits of $300,000. The agreement provides severance and full equity vesting if his employment is terminated other than for cause, with enhanced benefits in a change-in-control scenario.
Current CFO Austen B. Helfrich will depart the same day, January 12, 2026. His exit is governed by the “termination other than for cause” provisions of his employment agreement and is not due to any disagreement with management or the external auditor. The company expects to record an estimated $5 million charge in the quarter ending March 31, 2026 related to his separation.
Healthcare Realty Trust Incorporated established an at-the-market equity offering program for up to $1,000,000,000 of its Class A common stock, to be sold from time to time through multiple sales agents and via forward sale arrangements. Shares may be sold on the New York Stock Exchange or in privately negotiated transactions, and the company is not obligated to sell any shares and can suspend the program.
The company will issue shares under an existing shelf registration statement and has filed a prospectus supplement dated December 17, 2025. It plans to use net proceeds for general corporate purposes, including acquiring, developing, and redeveloping healthcare facilities and contributing capital to its operating partnership, and may also repay borrowings under its unsecured credit facility, in which affiliates of several sales agents are lenders and may receive a portion of those proceeds.
Healthcare Realty Trust (HR) filed an 8‑K stating it issued a press release announcing its earnings and dividend for the third quarter ended September 30, 2025. The company also furnished its Q3 2025 Supplemental Information. The press release is included as Exhibit 99.1 and the supplemental package as Exhibit 99.2, and both are referenced as available via the company’s website.